vs

Side-by-side financial comparison of FiscalNote Holdings, Inc. (NOTE) and RAPID MICRO BIOSYSTEMS, INC. (RPID). Click either name above to swap in a different company.

FiscalNote Holdings, Inc. is the larger business by last-quarter revenue ($22.2M vs $11.3M, roughly 2.0× RAPID MICRO BIOSYSTEMS, INC.). On growth, RAPID MICRO BIOSYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs -24.7%). FiscalNote Holdings, Inc. produced more free cash flow last quarter ($-1.9M vs $-3.3M). Over the past eight quarters, RAPID MICRO BIOSYSTEMS, INC.'s revenue compounded faster (41.8% CAGR vs -16.8%).

FiscalNote Holdings, Inc., or commonly FiscalNote, is a publicly traded software, data, and media company headquartered in Washington, D.C. The company was founded by Timothy Hwang, Gerald Yao, and Jonathan Chen in 2013. FiscalNote provides software tools, platforms, data services, and news through the FiscalNote Government Relationship Management (GRM) service, its core product. The company also uses an artificial intelligence platform to analyze proposed U.S. legislation based on key phrase...

Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.

NOTE vs RPID — Head-to-Head

Bigger by revenue
NOTE
NOTE
2.0× larger
NOTE
$22.2M
$11.3M
RPID
Growing faster (revenue YoY)
RPID
RPID
+61.9% gap
RPID
37.3%
-24.7%
NOTE
More free cash flow
NOTE
NOTE
$1.4M more FCF
NOTE
$-1.9M
$-3.3M
RPID
Faster 2-yr revenue CAGR
RPID
RPID
Annualised
RPID
41.8%
-16.8%
NOTE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NOTE
NOTE
RPID
RPID
Revenue
$22.2M
$11.3M
Net Profit
$-12.5M
Gross Margin
Operating Margin
-83.7%
-108.2%
Net Margin
-110.8%
Revenue YoY
-24.7%
37.3%
Net Profit YoY
-29.3%
EPS (diluted)
$-2.81
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NOTE
NOTE
RPID
RPID
Q4 25
$22.2M
$11.3M
Q3 25
$22.4M
$7.8M
Q2 25
$23.3M
$7.3M
Q1 25
$27.5M
$7.2M
Q4 24
$29.5M
$8.2M
Q3 24
$29.4M
$7.6M
Q2 24
$29.2M
$6.6M
Q1 24
$32.1M
$5.6M
Net Profit
NOTE
NOTE
RPID
RPID
Q4 25
$-12.5M
Q3 25
$-24.9M
$-11.5M
Q2 25
$-13.3M
$-11.9M
Q1 25
$-4.3M
$-11.3M
Q4 24
$-9.7M
Q3 24
$-14.9M
$-11.3M
Q2 24
$-12.8M
$-12.6M
Q1 24
$50.6M
$-13.3M
Operating Margin
NOTE
NOTE
RPID
RPID
Q4 25
-83.7%
-108.2%
Q3 25
-43.4%
-145.1%
Q2 25
-31.9%
-167.3%
Q1 25
-50.0%
-161.8%
Q4 24
-19.4%
-124.5%
Q3 24
-23.1%
-158.3%
Q2 24
-27.2%
-202.1%
Q1 24
-35.6%
-254.4%
Net Margin
NOTE
NOTE
RPID
RPID
Q4 25
-110.8%
Q3 25
-110.8%
-146.8%
Q2 25
-57.0%
-163.3%
Q1 25
-15.4%
-156.3%
Q4 24
-117.6%
Q3 24
-50.7%
-148.9%
Q2 24
-43.6%
-190.1%
Q1 24
157.6%
-237.4%
EPS (diluted)
NOTE
NOTE
RPID
RPID
Q4 25
$-2.81
$-0.26
Q3 25
$-1.73
$-0.26
Q2 25
$-0.08
$-0.27
Q1 25
$-0.03
$-0.26
Q4 24
$1.88
$-0.22
Q3 24
$-1.33
$-0.26
Q2 24
$-0.09
$-0.29
Q1 24
$0.37
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NOTE
NOTE
RPID
RPID
Cash + ST InvestmentsLiquidity on hand
$26.3M
$20.0M
Total DebtLower is stronger
$128.4M
Stockholders' EquityBook value
$62.0M
$33.2M
Total Assets
$255.1M
$74.9M
Debt / EquityLower = less leverage
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NOTE
NOTE
RPID
RPID
Q4 25
$26.3M
$20.0M
Q3 25
$31.2M
$18.9M
Q2 25
$38.5M
$18.3M
Q1 25
$46.3M
$18.9M
Q4 24
$34.6M
$16.9M
Q3 24
$32.7M
$22.0M
Q2 24
$37.7M
$37.1M
Q1 24
$43.6M
$22.4M
Total Debt
NOTE
NOTE
RPID
RPID
Q4 25
$128.4M
Q3 25
$131.5M
Q2 25
$116.7M
Q1 25
$118.0M
Q4 24
$147.1M
Q3 24
$152.2M
Q2 24
$145.9M
Q1 24
$153.0M
Stockholders' Equity
NOTE
NOTE
RPID
RPID
Q4 25
$62.0M
$33.2M
Q3 25
$75.5M
$44.3M
Q2 25
$95.1M
$54.5M
Q1 25
$98.7M
$65.5M
Q4 24
$97.8M
$75.4M
Q3 24
$98.5M
$84.4M
Q2 24
$106.9M
$94.6M
Q1 24
$106.1M
$105.9M
Total Assets
NOTE
NOTE
RPID
RPID
Q4 25
$255.1M
$74.9M
Q3 25
$273.9M
$84.4M
Q2 25
$288.3M
$75.6M
Q1 25
$299.7M
$85.4M
Q4 24
$326.2M
$98.2M
Q3 24
$337.9M
$105.8M
Q2 24
$346.3M
$117.1M
Q1 24
$357.8M
$127.7M
Debt / Equity
NOTE
NOTE
RPID
RPID
Q4 25
2.07×
Q3 25
1.74×
Q2 25
1.23×
Q1 25
1.20×
Q4 24
1.50×
Q3 24
1.54×
Q2 24
1.36×
Q1 24
1.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NOTE
NOTE
RPID
RPID
Operating Cash FlowLast quarter
$-279.0K
$-3.2M
Free Cash FlowOCF − Capex
$-1.9M
$-3.3M
FCF MarginFCF / Revenue
-8.7%
-29.6%
Capex IntensityCapex / Revenue
7.4%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-18.6M
$-31.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NOTE
NOTE
RPID
RPID
Q4 25
$-279.0K
$-3.2M
Q3 25
$-8.3M
$-9.1M
Q2 25
$-6.2M
$-9.7M
Q1 25
$3.3M
$-9.1M
Q4 24
$-1.3M
$-9.9M
Q3 24
$-3.0M
$-8.6M
Q2 24
$-3.7M
$-10.1M
Q1 24
$2.7M
$-15.5M
Free Cash Flow
NOTE
NOTE
RPID
RPID
Q4 25
$-1.9M
$-3.3M
Q3 25
$-10.4M
$-9.1M
Q2 25
$-7.7M
$-10.1M
Q1 25
$1.3M
$-9.4M
Q4 24
$-3.4M
$-10.0M
Q3 24
$-5.4M
$-8.8M
Q2 24
$-6.5M
$-10.6M
Q1 24
$1.0M
$-16.1M
FCF Margin
NOTE
NOTE
RPID
RPID
Q4 25
-8.7%
-29.6%
Q3 25
-46.2%
-116.4%
Q2 25
-33.0%
-138.6%
Q1 25
4.7%
-130.2%
Q4 24
-11.4%
-121.8%
Q3 24
-18.4%
-116.0%
Q2 24
-22.1%
-159.8%
Q1 24
3.3%
-287.1%
Capex Intensity
NOTE
NOTE
RPID
RPID
Q4 25
7.4%
0.8%
Q3 25
9.3%
0.9%
Q2 25
6.4%
5.0%
Q1 25
7.2%
4.4%
Q4 24
6.8%
1.2%
Q3 24
8.3%
2.9%
Q2 24
9.4%
6.9%
Q1 24
5.3%
10.4%
Cash Conversion
NOTE
NOTE
RPID
RPID
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NOTE
NOTE

Subscription$21.2M95%
Advisory Advertising And Other$1.0M5%

RPID
RPID

Products$9.3M83%
Services$2.0M17%

Related Comparisons